For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on November 1st, 2023 | 06:10 CET
More than 300% share price opportunity: BioNTech, Morphosys and Cardiol Therapeutics
Study results, along with acquisitions by Big Pharma, are the drivers of biotech company share prices. However, in the current challenging stock market environment, even positive data can be overlooked. But this opens up opportunities for investors with a little more staying power. Sooner or later, the information is recognized, and stock prices rise, or a pharmaceutical giant makes a move. At BioNTech, for example, the price reaction to the long-awaited news from the cancer pipeline has failed to materialize. Analysts are also cautious. Cardiol Therapeutics is a different story. The Canadians have taken on the fight against heart disease and are making significant progress in their research. The share had more than doubled to EUR 1.08 by the summer. Several analysts see the current setback as a buying opportunity. Experts are also giving the thumbs up to German biotech pioneer Morphosys.
Read
Commented by Fabian Lorenz on October 26th, 2023 | 09:10 CEST
Analysts love cash flow stocks: Nel, Volkswagen, Saturn Oil + Gas
What do investors and analysts dislike in times of high interest rates? Losses and debt. By contrast, they love high cash flow. Free cash flow. With it, a company can finance itself, pay off debt or distribute money to shareholders. And this is precisely Nel's problem. While the loss has been reduced, the Norwegians are still a long way from generating positive cash flow. But analysts still see potential. Analysts see more than 100% upside potential for Saturn Oil & Gas. The oil producer is developing into a cash flow monster, and the upcoming quarterly figures should be convincing again. Volkswagen is also winning over experts. Can the VW share really double? However, there is also a sell recommendation.
Read
Commented by Fabian Lorenz on October 25th, 2023 | 08:10 CEST
New stock favorites? BYD, JinkoSolar, dynaCERT
Hydrogen, electromobility and solar energy are without doubt among the absolute industries of the future. The growth prospects for the coming years are excellent. However, companies from all these sectors are currently struggling on the stock market. Today, we take a look at new and old favorites. BYD's preliminary quarterly figures were compelling, and analysts are giving their approval. JinkoSolar is evolving into the number one in the solar sector, and the Chinese can be pleased about new orders. There is also positive news at dynaCERT. The hydrogen and emission reduction specialist could even be on the verge of a game-changer.
Read
Commented by Fabian Lorenz on October 19th, 2023 | 06:30 CEST
Hydrogen bull market ahead? Are Nel, Nikola and First Hydrogen shares ready for entry?
This year's sell-off in shares related to the energy and mobility transition sectors is tempting investors to enter. This is because the market trend remains positive. For example, the promotion of hydrogen in the US and Europe has taken concrete shape. The EU, Norway and the UK alone want to multiply electrolysis capacities from the current 143 MW to 138 GW by 2030. So, it should only be a matter of time before the next hydrogen boom. Robert Campbell is also confident, stating: "We are entering a renewables supercycle." This comes from the CEO of First Hydrogen at the International Investment Forum. The Canadian company is developing hydrogen fuel cell commercial vehicles and is approaching a significant event. At Nel, the focus is on the upcoming quarterly figures, among other things. Can the Norwegians perhaps surprise? Nikola has reported a milestone, but the stock has given up almost all of its gains from the summer.
Read
Commented by Fabian Lorenz on October 18th, 2023 | 06:50 CEST
Turnaround for Plug Power stock? Barrick Gold and Manuka Resources are also on the rise
Is this the turnaround for Plug Power? After all, the stock has gained about 20% in the past few days. Looking at the longer-term price chart of the hydrogen pioneer, this is only a small success, but at least it is a start. Barrick Gold's stock has also seen an upswing in recent days, and the outlook for the fourth quarter could give the gold company a further boost. The CEO of Australian resource company Manuka Resources has expressed optimism that the stock will soon reach higher prices. "For a company that is already producing gold and has two projects fully funded, we are extremely cheap at a valuation of AUD 25 million. So we should have seen the bottom," commented Dennis Karp at the recent IIF virtual investor conference. Where does this optimism come from?
Read
Commented by Fabian Lorenz on October 12th, 2023 | 07:15 CEST
Stocks for bargain hunters: BYD, JinkoSolar and Desert Gold
What do renewable energies and gold have in common? Despite attractive future prospects, shares from both sectors have taken a beating in recent months. Often for no apparent reason. This opens up opportunities for bargain hunters with a bit of patience. For example, with shares like JinkoSolar and Desert Gold. Both companies are historically cheap. JinkoSolar has just reported a new sales record and wants to grow further. Desert Gold lures with an almost ridiculously low valuation of its gold resources and continues to drill. A rebound or takeover beckons for patient investors. And BYD? The Chinese are on track to displace Tesla as the world's No. 1 e-car manufacturer. Nevertheless, the stock is stuck, and in Europe, the EU is investigating illegal subsidies.
Read
Commented by Fabian Lorenz on October 11th, 2023 | 08:10 CEST
Attention Price Jump! Tui, Plug Power and Defence Therapeutics with News
Alarm at Tui and Deutsche Lufthansa. Both stocks are influenced by the terrorist attack in Israel this week. While the oil price is surging, aviation and tourism stocks are declining. The Tui share had already been trending weakly before. Even the leap into the profit zone could not change this. And what do analysts say? Meanwhile, Defence Therapeutics shone with positive news on a cancer therapy. As a result, the biotech share gained yesterday, offering further potential for price increases. Plug Power's share price rose by a good 7% yesterday. What is behind this?
Read
Commented by Fabian Lorenz on October 5th, 2023 | 07:10 CEST
Buy biotech stocks now? BioNTech, Morphosys and Cardiol Therapeutics in check
In times of high interest rates, the wheat is separated from the chaff, even in the biotech sector. After all, young research-based companies, in particular, have a high demand for capital. But at the moment, all companies are being lumped together. This opens up clear buying opportunities because some have full coffers. BioNTech belongs to this group. Thanks to the COVID-19 vaccine, research is fully financed. The same goes for Cardiol Therapeutics. The share of the Canadians is one of the summer's high flyers, and the recent price setback offers an entry opportunity. The analysts' price target is over 300% above the current level. And what do analysts say about the German biotech veteran Morphosys? Goldman Sachs has tripled its price target.
Read
Commented by Fabian Lorenz on October 4th, 2023 | 08:15 CEST
Battery vs. hydrogen! Buy Nel ASA now? Or is FREYR Battery or Altech Advanced Materials better?
Should investors bet on battery stocks over hydrogen stocks? At least when looking at investor darlings like Nel and Plug Power, the answer to this question seems to be "yes" at the moment. The Nel share, in particular, has been hit hard. In local currency, it is trading at its lowest level since the beginning of 2020. Is there hope for a rebound? Or are investors better off betting on battery newcomers like FREYR Battery or Altech Advanced Materials? In terms of share price, Germany's Altech has been the best performer this year, and at the recent Capital Markets Day, management expressed confidence that it would soon take the battery market by storm. So, what is the current status of hopes for hydrogen and batteries?
Read
Commented by Fabian Lorenz on September 28th, 2023 | 07:10 CEST
BYD unstoppable. Sell Varta shares? 200% with Almonty Industries?
Electromobility and the energy transition offer numerous investment opportunities along the value chain. Take BYD, for example. The Chinese company is increasingly becoming the e-car market leader. Could they soon even dethrone Tesla? That should make the stock interesting. And what about Varta? The battery manufacturer disappointed investors last year. Is the stock attractive now? Analysts continue to take a critical view of the Company. Almonty Industries is a different story. After the latest half-year figures, the experts at Sphene Capital advise buying. From 2024, sales and profits of the tungsten producer are expected to grow strongly. According to the analysts, the share could triple.
Read